v3.25.0.1
Condensed Consolidated Statement of Changes in Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income/(Loss)
Treasury Stock
Non-Controlling Interest
Beginning balance at Mar. 31, 2023 $ 73,302 $ 376 $ 218,473 $ (135,961) $ (1,098) $ (8,554) $ 66
Beginning balance (in shares) at Mar. 31, 2023   37,621          
Increase (Decrease) in Stockholders' Equity              
Net loss attributable to common stockholders (6,171)   (2,902) (3,269)      
Net income attributable to non-controlling interest 6           6
Foreign currency translation adjustment 91       100   (9)
Issuance of restricted shares 0 $ 1 (1)        
Issuance of restricted shares (in shares)   162          
Shares withheld pursuant to vesting of restricted stock (4)         (4)  
Forfeiture of restricted shares (in shares)   (82)          
Exercise of stock options (in shares)   16          
Exercise of stock options 36   36        
Stock-based compensation 852   852        
Ending balance (in shares) at Jun. 30, 2023   37,717          
Ending balance at Jun. 30, 2023 68,112 $ 377 216,458 (139,230) (998) (8,558) 63
Beginning balance at Mar. 31, 2023 73,302 $ 376 218,473 (135,961) (1,098) (8,554) 66
Beginning balance (in shares) at Mar. 31, 2023   37,621          
Increase (Decrease) in Stockholders' Equity              
Net loss attributable to common stockholders (19,190)            
Net income attributable to non-controlling interest 38            
Shares issued in connection with Combination 0            
Ending balance (in shares) at Dec. 31, 2023   38,716          
Ending balance at Dec. 31, 2023 57,644 $ 387 212,703 (146,281) (616) (8,651) 102
Beginning balance at Jun. 30, 2023 68,112 $ 377 216,458 (139,230) (998) (8,558) 63
Beginning balance (in shares) at Jun. 30, 2023   37,717          
Increase (Decrease) in Stockholders' Equity              
Net loss attributable to common stockholders (6,510)   (2,962) (3,548)      
Foreign currency translation adjustment (906)       (906)    
Issuance of restricted shares 0 $ 10 (10)        
Issuance of restricted shares (in shares)   982          
Shares withheld pursuant to vesting of restricted stock (90)         (90)  
Stock-based compensation 1,101   1,101        
Ending balance (in shares) at Sep. 30, 2023   38,699          
Ending balance at Sep. 30, 2023 61,707 $ 387 214,587 (142,778) (1,904) (8,648) 63
Increase (Decrease) in Stockholders' Equity              
Net loss attributable to common stockholders (6,510)   (3,007) (3,503)      
Net income attributable to non-controlling interest 32           32
Foreign currency translation adjustment 1,295       1,288   7
Issuance of restricted shares 0 $ 2 (2)        
Issuance of restricted shares (in shares)   28          
Shares withheld pursuant to vesting of restricted stock (3)         (3)  
Forfeiture of restricted shares 0 $ (2) 2        
Forfeiture of restricted shares (in shares)   (11)          
Stock-based compensation 1,123   1,123        
Ending balance (in shares) at Dec. 31, 2023   38,716          
Ending balance at Dec. 31, 2023 57,644 $ 387 212,703 (146,281) (616) (8,651) 102
Beginning balance at Mar. 31, 2024 $ 38,636 $ 387 202,607 (154,796) (985) (8,682) 105
Beginning balance (in shares) at Mar. 31, 2024 37,212 38,709          
Increase (Decrease) in Stockholders' Equity              
Net loss attributable to common stockholders $ (22,337)   (25) (22,312)      
Net income attributable to non-controlling interest 13           13
Foreign currency translation adjustment 426       418   8
Issuance of restricted shares 0 $ 1 (1)        
Issuance of restricted shares (in shares)   54          
Shares issued for transaction bonus 889 $ 1 888        
Shares issued for transaction bonus (in shares)   174          
Shares issued in connection with Combination 362,005 $ 707 361,298        
Shares issued in connection with Combination (in shares)   70,704          
Acquired through MiX Combination 7,823   7,818       5
Shares withheld pursuant to vesting of restricted stock (2,836)         (2,836)  
Stock-based compensation 5,929   5,929        
Ending balance (in shares) at Jun. 30, 2024   109,641          
Ending balance at Jun. 30, 2024 390,548 $ 1,096 578,514 (177,108) (567) (11,518) 131
Beginning balance at Mar. 31, 2024 $ 38,636 $ 387 202,607 (154,796) (985) (8,682) 105
Beginning balance (in shares) at Mar. 31, 2024 37,212 38,709          
Increase (Decrease) in Stockholders' Equity              
Net loss attributable to common stockholders $ (38,573)            
Net income attributable to non-controlling interest 17            
Shares issued in connection with Combination $ 362,005            
Ending balance (in shares) at Dec. 31, 2024 132,493 134,556          
Ending balance at Dec. 31, 2024 $ 458,541 $ 1,339 669,492 (193,345) (7,578) (11,518) 151
Beginning balance at Jun. 30, 2024 390,548 $ 1,096 578,514 (177,108) (567) (11,518) 131
Beginning balance (in shares) at Jun. 30, 2024   109,641          
Increase (Decrease) in Stockholders' Equity              
Net loss attributable to common stockholders (1,888)     (1,888)      
Net income attributable to non-controlling interest 5           5
Foreign currency translation adjustment (777)       (797)   20
Proceeds from private placement, net of costs to issue common stock 61,851   61,851        
Exercise of stock options (in shares)   243          
Stock-based compensation 1,371   1,371        
Ending balance (in shares) at Sep. 30, 2024   109,884          
Ending balance at Sep. 30, 2024 451,110 $ 1,096 641,736 (178,996) (1,364) (11,518) 156
Increase (Decrease) in Stockholders' Equity              
Net loss attributable to common stockholders (14,349)     (14,349)      
Net income attributable to non-controlling interest (1)           (1)
Foreign currency translation adjustment (6,218)       (6,214)   (4)
Shares issued in connection with Combination 21,343 $ 43 21,300        
Shares issued in connection with Combination (in shares)   4,286          
Proceeds from private placement, net of costs to issue common stock (in shares)   20,000          
Proceeds from private placement, net of costs to issue common stock 4,608 $ 200 4,408        
Exercise of stock options (in shares)   161          
Exercise of stock options 910   910        
Stock-based compensation $ 1,138   1,138        
Issue of stock appreciation rights (in shares)   225          
Ending balance (in shares) at Dec. 31, 2024 132,493 134,556          
Ending balance at Dec. 31, 2024 $ 458,541 $ 1,339 $ 669,492 $ (193,345) $ (7,578) $ (11,518) $ 151